Literature DB >> 3032398

Antigenic phenotype of the lymphocytic component of medullary carcinoma of the breast.

J Ben-Ezra, K Sheibani.   

Abstract

Medullary carcinoma of the breast, which is usually associated with a dense lymphocytic infiltrate, carries a better prognosis than do most other histologic subtypes of breast carcinoma. We studied cryostat-cut fresh frozen sections from 12 patients with medullary carcinoma and, as controls, nine patients with infiltrating ductal carcinoma in order to determine and compare the antigenic phenotype of the lymphocytic components of these tumors. We used a large panel of monoclonal antibodies and polyclonal antisera for T-cells (Leu-1, Leu-2a, Leu-3a, Leu-9, T-3, T-6, T-10, T-11, and TQ-1), pre-B and B-cells (BA-1, B-1, B-2, B-4, and J5), NK cells (Leu-7 and Leu-11b), and cell activation associated antigens (T-9, HLA-Dr, and Tac). The most commonly encountered antigens on the lymphocytic components of both medullary carcinoma and infiltrating ductal carcinoma were: T-3, T-11, Leu-1, Leu-2a, Leu-3a, and Leu-9. There was little staining for NK-, pre-B-, or B-cell associated antigens in either type of carcinoma. However, the lymphocytes in the control cases tended to express HLA-Dr and T-10 more often than did the lymphocytes in the cases of medullary breast carcinoma. Our data indicate that: the antigenic phenotypes of the lymphocytic infiltrates of medullary carcinoma and those of infiltrating ductal carcinoma of the breast are essentially similar; and the lymphocytes in these carcinomas are composed predominantly of peripheral T-lymphocytes. We therefore conclude that the favorable biologic behavior of medullary carcinoma of the breast cannot readily be explained by the immunophenotype of its lymphocytic component.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032398     DOI: 10.1002/1097-0142(19870615)59:12<2037::aid-cncr2820591212>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.

Authors:  M Feinmesser; A Sulkes; S Morgenstern; J Sulkes; S Stern; E Okon
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

2.  Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast.

Authors:  Hajime Kuroda; Jun-ichi Tamaru; Goi Sakamoto; Kiyoshi Ohnisi; Shinji Itoyama
Journal:  Virchows Arch       Date:  2004-11-30       Impact factor: 4.064

3.  The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.

Authors:  M H Hansen; H Nielsen; H J Ditzel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

4.  Medullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behavior.

Authors:  S S Bacus; C R Zelnick; D M Chin; Y Yarden; D B Kaminsky; J Bennington; D Wen; J N Marcus; D L Page
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

5.  Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia.

Authors:  L J McGuire; D P Huang; R Teoh; M Arnold; K Wong; J C Lee
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

6.  Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.

Authors:  P Whitford; E A Mallon; W D George; A M Campbell
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.